The University of Missouri System is an American state university system providing centralized administration for four universities, a health care system, an extension program, and ten research and technology parks. Nearly 70,000 students are currently enrolled at its four campuses. The health care system operates several hospitals and clinics in central Missouri, while the extension program provides distance learning and other educational initiatives statewide.The UM System was created in 1963 when the University of Missouri (founded in 1839 in Columbia) and the Missouri School of Mines (now the Missouri University of Science and Technology, founded in 1870 in Rolla), were combined with the formerly private University of Kansas City (now University of Missouri–Kansas City, founded in 1933), and a newly created campus in suburban St. Louis (University of Missouri–St. Louis) in 1963.....
Solar-driven catalytic decontamination of emerging organic pollutants is of significance for achieving environmental sustainability. The cardinal challenges in this technology are swift charge carrier reunion, weak redox capability and poor sunlight utilization capacity of photocatalysts. Here, an innovative Ag/Ag2 O/C3 N5 S-scheme heterojunction photocatalyst with plasmonic effect was developed for antibiotic decontamination by coating Ag/Ag2 O nanodots on the surface of C3 N5 nanosheets. The localized surface plasmon resonance (LSPR) effect from Ag nanodots augments sunlight response and exciton production. Meanwhile the "nanodots-on-nanosheets" 0D/0D/2D heterostructure with a plasmonic S-scheme interface significantly boosts separation and utilization of highly energetic photo-carriers. As a result, the optimized Ag/Ag2 O/C3 N5 demonstrates extraordinary stability and achieves a photocatalytic levofloxacin removal rate constant of 0.0278 min-1 , which is about 3.9-, 11.6-, and 1.9-fold greater than that of Ag2 O, C3 N5 , and Ag2 O/C3 N5, respectively. The photocatalytic decontamination mechanism and degradation route of levofloxacin over Ag/Ag2 O/C3 N5 are elucidated using LC-MS analysis and DFT calculation. This research highlights the potential of LSPR modulated S-scheme heterojunctions as robust photocatalysts for wastewater decontamination, paving the way for innovative solutions to environmental pollution challenges. (c) 2025 Published by Elsevier Ltd on behalf of The editorial office of Journal of Materials Science & Technology.
Introduction Proteinuria is a modifiable risk factor for chronic kidney disease (CKD) progression in children. Finerenone, a selective, non-steroidal, mineralocorticoid receptor antagonist (MRA) has been approved to treat adults with CKD associated with type 2 diabetes mellitus (T2DM) following results from the phase III clinical trials FIDELIO-DKD (NCT02540993) and FIGARO-DKD (NCT02545049). In a pre-specified pooled analysis of both studies ( N = 13,026), finerenone was shown to have an acceptable safety profile and was efficacious in decreasing the risk of adverse kidney and cardiovascular outcomes and of proteinuria. Objective FIONA and the associated open-label extension (OLE) study aim to demonstrate that combining finerenone with an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) is safe, well-tolerated, and effective in sustainably reducing urinary protein excretion in children with CKD and proteinuria. Design FIONA (NCT05196035; Eudra-CT: 2021–002071-19) is a randomized (2:1), double-blind, placebo-controlled, multicenter, phase III study of 6 months’ duration in approximately 219 pediatric patients. Patients must have a clinical diagnosis of CKD (an eGFR ≥ 30 mL/min/1.73 m 2 if ≥ 1 to < 18 years or a serum creatinine level ≤ 0.40 mg/dL for infants 6 months to < 1 year) with significant proteinuria despite ACEi or ARB usage. The primary objective is to demonstrate that finerenone, added to an ACEi or ARB, is superior to placebo in reducing urinary protein excretion. FIONA OLE (NCT05457283; Eudra-CT: 2021–002905-89) is a single-arm, open-label study, enrolling participants who have completed FIONA. The primary objective of FIONA OLE is to provide long-term safety data. FIONA has two primary endpoints: urinary protein-to-creatinine ratio (UPCR) reduction of ≥ 30% from baseline to day 180 and percent change in UPCR from baseline to day 180. A sample size of 198 participants (aged 2 to < 18 years) in FIONA will provide at least 80% power to reject the null hypothesis of either of the two primary endpoints. Conclusion FIONA is evaluating the use of finerenone in children with CKD and proteinuria. Should safety, tolerability, and efficacy be demonstrated, finerenone could become a useful additional therapeutic agent in managing proteinuria and improving kidney outcomes in children with CKD. Trial registration ClinicalTrials.gov NCT05196035. Registered on 19 January 2022.
This study evaluates the effect of two different quench practices on distortion, sensitivity to quench cracking, development and distribution of residual stress, microstructural uniformity, and hardenability of standardized test castings. Navy C-rings made of AISI 4340 were quenched in this experiment. Some rings were quenched in a conventional draft tube immersion quench bath, and others were quenched in an intensive quench spray system to compare with the results from the conventional immersion quench bath. The rings were measured with a coordinate measuring machine, for distortion and flatness, before and after quenching. Hardness profiles of the quenched rings showed through hardness of 57.0-59.0 HRC, and the microstructures were largely martensitic. DANTE modeling software was used to predict the quenched properties of the rings, simulating microstructural transformation and residual stresses for each quench practice. XRD was used to measure surface residual stress distribution of the quenched rings, and results were compared to the predicted values by the modeling software. The surface residual stress was tensile for the conventional immersion quench and compressive for the intensive spray quench. Crack initiation correlated to areas of large tensile stress concentration and microstructural heterogeneity.
This study introduces the existence of one positive solution for a specific category of semipositive singular three-point boundary value problems associated with Caputo fractional differential equations. The proof relies on the application of the Guo-Krasnosel'skii fixed point theorem. In the end, we provide an illustrative example.
The thermo-mechanical properties of SiC particulate-reinforced SiC composites (SiC-PRCs), fabricated using precursor impregnation & pyrolysis (PIP) process, were analyzed up to 2000 degrees C. The relative density of the SiCPRCs after 4 PIP cycles was 88.6 %. The number of PIP cycles required decreased to nearly half compared with the conventional PIP method by using ultra-high concentration slurries up to 70 vol%. In addition, roomtemperature bending strength (215 MPa) and Young's modulus (269 GPa) improved as the solid loading of the slurry increased. The bending strength increased to 232 MPa at 2000 degrees C in Ar. Despite the thermal deterioration of the precursor-derived ceramics (PDC), the mechanical properties of the PRC did not deteriorate up to 2000 degrees C because the PDC fixed the position of thermally stable SiC filler particles, which were densely packed and mostly endured the stress. Moreover, partial densification at high temperature further improved the thermomechanical properties of the PRC.